CA Patent

CA3207897A1 — Improved oligonucleotide synthesis

Assigned to Bachem Holding AG · Expires 2022-09-22 · 4y expired

What this patent protects

An improved protocol for the synthesis of oligonucleotides is provided, which reduces the level of depurination. A liquid composition for the cleavage of a di(p-methoxyphenyl) phenylmethyl protecting group from a hydroxyl group and the use thereof in chemical synthesis of oligonu…

USPTO Abstract

An improved protocol for the synthesis of oligonucleotides is provided, which reduces the level of depurination. A liquid composition for the cleavage of a di(p-methoxyphenyl) phenylmethyl protecting group from a hydroxyl group and the use thereof in chemical synthesis of oligonucleotides is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
CA3207897A1
Jurisdiction
CA
Classification
—
Expires
2022-09-22
Drug substance claim
No
Drug product claim
No
Assignee
Bachem Holding AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.